Kevin Balthaser
Vermögen: 852 911 $ am 31.05.2026
Vermögen: 852 911 $ am 31.05.2026
Kevin Balthaser currently holds the position of Chief Financial Officer & Accounting Officer at Aclaris Therapeutics, Inc. since 2023 and has been with the company since 2017.
Kevin is also a member of The American Institute of Certified Public Accountants.
Mr. Balthaser completed undergraduate studies at The Pennsylvania State University and earned an MBA from Villanova University in 1990.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 14.04.2026 | 187.453 ( 0,13 % ) | 852 911 $ | 31.05.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| ACLARIS THERAPEUTICS, INC. | Finanzdirektor/CFO | 01.01.2023 |
The American Institute of Certified Public Accountants
The American Institute of Certified Public Accountants Miscellaneous Commercial ServicesCommercial Services Association of accountants | Corporate Officer/Principal | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 4 |
|---|---|
Aclaris Therapeutics, Inc.
Aclaris Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel drug candidates for immuno-inflammatory diseases | Health Technology |
The American Institute of Certified Public Accountants
The American Institute of Certified Public Accountants Miscellaneous Commercial ServicesCommercial Services Association of accountants | Commercial Services |
The Pennsylvania State University
The Pennsylvania State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Villanova University
Villanova University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen